Review
Published on 06 Sep 2019
Molecular Approaches to Treating Pediatric Leukemias
in Pediatric Hematology and Hematological Malignancies
Frontiers in Pediatrics
doi 10.3389/fped.2019.00368
- 10,261 views
- 37 citations
6 articles related to "Risk Adapted Therapy"
Articles
Review
Published on 29 Nov 2021
Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.750789
- 50,581 views
- 53 citations
Original Research
Published on 27 Mar 2024
Evaluation of AJCC staging system and proposal of a novel stage grouping system in retroperitoneal liposarcoma: the Fudan Zhongshan experience
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1373762
- 3,193 views
- 2 citations
Original Research
Published on 04 Apr 2025
HLA-mismatched stem cell microtransplant prolonged overall survival and promoted immunological reconstitution for multiple myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1509588
- 2,342 views
Original Research
Published on 13 Dec 2022
Survival trends and prognostic factors for patients with extramedullary plasmacytoma: A population-based study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1052903
- 3,979 views
- 8 citations
Original Research
Published on 28 Jul 2025
Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexico
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1614445
- 3,375 views
- 4 citations